Showing results (231-240 of 606) with videos related to
Sort By:
Pageof 61
Surgical Oncology|July 17, 2026
Comparison of long-term outcomes between liver transplantation and liver resection for intrahepatic cholangiocarcinoma: An updated systematic review and meta-analysisJiro Kimura, Ayham Asassfeh, Toshihide Tomosugi, et al.Health Psychology Review|August 2, 2023
Identifying the active ingredients of training interventions for healthcare professionals to promote and support increased levels of physical activity in adults with heart failure: a systematic reviewKirsten Ashley, Mei Yee Tang, Darren Flynn, et al.American Journal of Hematology|August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromesMike G Martin, Richard A Walgren, Elizabeth Procknow, et al.Stem Cells (Dayton, Ohio)|January 15, 2015
Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiationYi Zeng, Hal E Broxmeyer, Karl Staser, et al.Leukemia Research|October 7, 2021
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDSEric Huselton, Michael P Rettig, Kirsten Campbell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell LymphomaJoseph M Tuscano, Emanual Maverakis, Susan Groshen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphomaAmy L Hoerr, Feng Gao, Josephine Hidalgo, et al.ACS Nano|May 10, 2016
Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and MetastasisYongfeng Zhao, Lisa Detering, Deborah Sultan, et al.Cancer|April 16, 2017
Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemiaHanna J Khoury, Robert H Collins, William Blum, et al.JAMA Cardiology|December 2, 2020
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life: A ReviewLucas C Godoy, Claudia Frankfurter, Matthew Cooper, et al.Pageof 61